We are live on ! Find out more
BDWM

Brewin Dolphin Wealth Management Portfolio holdings

AUM $917M
1-Year Est. Return 12.3%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
-12.3%
3 Year Est. Return
+47.8%
5 Year Est. Return
+88.28%
10 Year Est. Return
AUM
$655M
AUM Growth
+$60.5M
Cap. Flow
+$34.9M
Cap. Flow %
5.32%
Top 10 Hldgs %
59.77%
Holding
328
New
49
Increased
89
Reduced
42
Closed
8

Top Sells

Rank Stock Value
1
AYX
Alteryx Inc
AYX
+$1.28M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$491K
3
SPOT icon
Spotify
SPOT
+$334K
4
META icon
Meta Platforms (Facebook)
META
+$236K
5
RMD icon
ResMed
RMD
+$214K

Sector Composition

Rank Sector Weight
1 Financials 21.41%
2 Technology 11.35%
3 Healthcare 9.01%
4 Communication Services 7.74%
5 Consumer Staples 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECH icon
276
iShares MSCI Chile ETF
ECH
$1.06B
$13.7K ﹤0.01%
400
EPD icon
277
Enterprise Products Partners
EPD
$81.7B
$13.2K ﹤0.01%
600
PBI icon
278
Pitney Bowes
PBI
$2.39B
$13.2K ﹤0.01%
1,600
F icon
279
Ford
F
$55.7B
$12.8K ﹤0.01%
1,048
BA icon
280
Boeing
BA
$185B
$12.7K ﹤0.01%
50
-9
-15% -$2K
DAL icon
281
Delta Air Lines
DAL
$60.1B
$12.6K ﹤0.01%
260
ICLN icon
282
iShares Global Clean Energy ETF
ICLN
$2.4B
$12.2K ﹤0.01%
500
+370
+285% +$10.3K
RKTO
283
Rocket One Inc
RKTO
$18.9M
$11.8K ﹤0.01%
240
TEL icon
284
TE Connectivity
TEL
$62.6B
$11.7K ﹤0.01%
91
-109
-55% -$14K
BSX icon
285
Boston Scientific
BSX
$71.5B
$11.6K ﹤0.01%
300
MRNA icon
286
Moderna
MRNA
$23.6B
$11K ﹤0.01%
84
-140
-63% -$20.3K
SPRO icon
287
Spero Therapeutics
SPRO
$73M
$8.83K ﹤0.01%
600
KYNB
288
Kyntra Bio
KYNB
$29.4M
$8.68K ﹤0.01%
10
-15
-60% -$16K
STEX
289
Streamex Corp
STEX
$83M
$8.62K ﹤0.01%
200
OXY icon
290
Occidental Petroleum
OXY
$55.9B
$7.8K ﹤0.01%
293
LMND icon
291
Lemonade
LMND
$4.1B
$7.64K ﹤0.01%
+82
New +$10.6K
ARKW icon
292
ARK Web x.0 ETF
ARKW
$1.76B
$7.37K ﹤0.01%
50
-50
-50% -$8.07K
EMQQ icon
293
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$278M
$6.39K ﹤0.01%
100
EDIT icon
294
Editas Medicine
EDIT
$442M
$6.3K ﹤0.01%
150
-130
-46% -$7.41K
RNAM
295
DELISTED
Avidity Biosciences
RNAM
$5.89K ﹤0.01%
+270
New +$6.61K
AMD icon
296
Advanced Micro Devices
AMD
$789B
$5.81K ﹤0.01%
74
PANW icon
297
Palo Alto Networks
PANW
$297B
$5.8K ﹤0.01%
108
INFN
298
DELISTED
Infinera Corporation Common Stock
INFN
$5.78K ﹤0.01%
+600
New +$5.88K
SDGR icon
299
Schrodinger
SDGR
$1.36B
$5.64K ﹤0.01%
+74
New +$6.65K
TMPO
300
DELISTED
Tempo Automation Holdings, Inc. Common Stock
TMPO
$5.58K ﹤0.01%
+560
New +$6.17K

Similar funds

Brewin Dolphin Wealth Management's Q1 2021 Portfolio in Review

As of Q1 2021, Brewin Dolphin Wealth Management held 328 positions worth $655M, up 10% from $594M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Brewin Dolphin Wealth Management deployed $34.9M of net new capital in Q1 2021, opening 49 new positions and adding to 89 existing holdings. Its largest new stake was BioXcel Therapeutics: 125 shares worth $86.3K.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Alteryx Inc, an estimated $1.28M trimmed.

  • Brewin Dolphin Wealth Management's largest Q1 2021 buy was BioXcel Therapeutics: 125 shares worth $86.3K.
  • Brewin Dolphin Wealth Management added most to Berkshire Hathaway Class B in Q1 2021, an estimated $6.41M increase.
  • Brewin Dolphin Wealth Management's biggest Q1 2021 reduction was Alteryx Inc, cutting an estimated $1.28M.
  • Brewin Dolphin Wealth Management fully exited Brookfield Property Partners L.P. Limited Partnership Units in Q1 2021, selling an estimated $91.2K.
  • Brewin Dolphin Wealth Management's ten largest holdings make up 60% of its $655M portfolio in Q1 2021.
  • Brewin Dolphin Wealth Management opened 49 new positions and closed 8 in Q1 2021.
  • Brewin Dolphin Wealth Management's portfolio value rose 10% quarter-over-quarter to $655M.

Based on Brewin Dolphin Wealth Management's 13F filing for Q1 2021, filed 9 Nov 2023.